Some unspecified error has occurred.

Professor Chris Abell

November 11, 1957 - October 26, 2020

Professor Chris Abell FRS FMedsci was Pro-Vice Chancellor for Research, and Professor of Biological Chemistry at the University of Cambridge. A biological chemist, he was an undergraduate and postgraduate at Cambridge, before doing postdoctoral research at Brown University, USA. Chris was admitted as a Fellow of Christ's College in 1986. He led research teams in the Department of Chemistry pioneering the use of fragment-based approaches in drug discovery and developing microdroplets as an experimental platform. Chris cofounded Astex, Sphere Fluidics and Aqdot, and was a founding director of Cambridge Enterprise. From 2013-2015 Chris was the first Director of Postdoctoral Affairs at the University.

More... Less...

  • Memories Memories
    One moment please, your post is being saved...
  • Image Image
    To attach an image drag & drop it here or
    One moment please, your post is being saved...
  • Video Video
    Upload a video on YouTube and paste the code here:
    One moment please, your post is being saved...
  • Condolences Condolences
  • Condolences Condolences
    One moment please, your post is being saved...

2020-12-03 19:37:01 wrote:

I was incredibly sad to read this awful news in Chem@Cam just now. Working towards my MSci research project in m. TB in the Abell lab in 2013 was the absolute highlight of my scientific life and a total joy. He was so supportive and capable, and he represents a great loss to the university, the city of Cambridge and the whole scientific community. I am so terribly sorry.

2020-12-03 19:37:01 wrote: I was incredibly sad to read this awful news in Chem@Cam just now. Working towards my MSci research project in m. TB in the Abell lab in 2013 was the absolute highlight of my scientific life and a total joy. He was so supportive and capable, and he represents a great loss to the university, the city of Cambridge and the whole scientific community. I am so terribly sorry.

Comments (0)

  • No comments.